Yiping He

3.6k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Yiping He is a scholar working on Cancer Research, Genetics and Molecular Biology. According to data from OpenAlex, Yiping He has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Yiping He's work include Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Yiping He is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Yiping He collaborates with scholars based in China, United States and Japan. Yiping He's co-authors include Bert Vogelstein, Kenneth W. Kinzler, Kerstin A. David, Meng Li, Dong Shen, Steve Szabo, Hartmut Juhl, Steven N. Goodman, Devin Dressman and Luis A. Díaz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Advanced Functional Materials.

In The Last Decade

Yiping He

18 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection and quantification of mutations in the plasma of patients with colorectal tumors

2005 939 citations Frank Diehl, Meng Li et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Yiping He

Since Specialization

Citations

This map shows the geographic impact of Yiping He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiping He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiping He more than expected).

Fields of papers citing papers by Yiping He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiping He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiping He. The network helps show where Yiping He may publish in the future.

Co-authorship network of co-authors of Yiping He

This figure shows the co-authorship network connecting the top 25 collaborators of Yiping He. A scholar is included among the top collaborators of Yiping He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiping He. Yiping He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	EC‐Less Electrolytes for High‐Safety and Long‐Life Nickel‐Rich Lithium‐Ion Batteries 2025 ·Advanced Functional Materials ·Yiping He, T. Chen, Yuelin Zhang, Yao Shi, Liang Yu, Yanshuang Hao, Yuchen Tan, (unknown), (unknown), (unknown), Chengshan Xu, Nao Kobayashi, (unknown), Gaolong Zhu, Shigeaki Yamazaki, Junxian Hou, (unknown), Languang Lu, (unknown), Minggao Ouyang	2
2	The Impact of China’s Family Floating Population on the Participation of Medical Insurance in the Inflow Areas 2024 ·Journal of Multidisciplinary Healthcare ·Yiping He, (unknown), (unknown), (unknown)	2
3	Profitable development technology of the Changning-Weiyuan National Shale Gas Demonstration Area in the Sichuan Basin and its enlightenment 2023 ·Natural Gas Industry B ·Rui Yong, Gengsheng Chen, (unknown), (unknown), Bo Li, (unknown), (unknown), Yiping He	14
4	Thinking on Effective Methods of Successful Prediction of Geological Hazards in Shaanxi, China 2023 ·International Journal of Geosciences ·(unknown), Frank Yonghong Li, Yiping He, Hui Li, (unknown), Ping Fang	2
5	TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist 2021 ·Acta Neuropathologica Communications ·Cheng Xu, Heng Liu, Christopher J. Pirozzi, Lee H. Chen, Paula K. Greer, Bill H. Diplas, Liwei Zhang, Matthew S. Waitkus, Yiping He, Hai Yan	12
6	Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor 2021 ·Frontiers in Oncology ·Yiwei Li, Yiping He, Fangqi Liu, Junjie Peng, Sanjun Cai, Ye Xu, Minghe Wang	11
7	Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence 2020 ·Acta Biochimica et Biophysica Sinica ·Yiping He, (unknown), Ke Chen, Yunwei Sun	4
8	The safety and effectiveness of carbon nanoparticles suspension in tracking lymph node metastases of colorectal cancer: a prospective randomized controlled trial 2020 ·Japanese Journal of Clinical Oncology ·Renjie Wang, Shaobo Mo, Qi Liu, Wenming Zhang, (unknown), Yiping He, Guoxiang Cai, Xinxiang Li	29
9	Gene signature associated with neuro‐endocrine activity predicting prognosis of pancreatic carcinoma 2019 ·Molecular Genetics & Genomic Medicine ·Ke Chen, Yiping He, Yuan Liu, Xiujiang Yang	11
10	Simple Vascular Architecture Classification in Predicting Pancreatic Neuroendocrine Tumor Grade and Prognosis 2018 ·Digestive Diseases and Sciences ·Ke Chen, Wenming Zhang, (unknown), Yiping He, Yuan Liu, Xiujiang Yang	9
11	Sensitive and rapid detection ofTERTpromoter andIDHmutations in diffuse gliomas 2018 ·Neuro-Oncology ·Bill H. Diplas, (unknown), Rui Yang, Landon J. Hansen, (unknown), Fangping Zhao, Darell D. Bigner, Roger E. McLendon, Yuchen Jiao, Yiping He, Matthew S. Waitkus, Hai Yan	31
12	Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression 2017 ·Molecular Cancer Research ·Christopher J. Pirozzi, Austin B. Carpenter, Matthew S. Waitkus, Catherine Y. Wang, Huishan Zhu, Landon J. Hansen, Lee H. Chen, Paula K. Greer, Jie Feng, Yu Wang, Cheryl B. Bock, Ping Fan, Ivan Spasojević, Roger E. McLendon, Darell D. Bigner, Yiping He, Hai Yan	31
13	The genetic landscape of anaplastic astrocytoma 2013 ·Oncotarget ·Patrick Killela, Christopher J. Pirozzi, Zachary J. Reitman, Siân Jones, B. Ahmed Rasheed, Eric Lipp, Henry S. Friedman, Allan H. Friedman, Yiping He, Roger E. McLendon, Darell D. Bigner, Hai Yan	56
14	Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas 2012 ·Cancer Research ·Genglin Jin, Zachary J. Reitman, Christopher G. Duncan, Ivan Spasojević, David M. Gooden, B. Ahmed Rasheed, Rui Yang, Giselle Y. López, Yiping He, Roger E. McLendon, Darell D. Bigner, Hai Yan	98
15	Mutant IDH1 is required for IDH1 mutated tumor cell growth 2012 ·Oncotarget ·Genglin Jin, Christopher J. Pirozzi, Lee H. Chen, Giselle Y. López, Christopher G. Duncan, Jie Feng, Ivan Spasojević, Darell D. Bigner, Yiping He, Hai Yan	31
16	Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome 2011 ·Proceedings of the National Academy of Sciences ·Zachary J. Reitman, Genglin Jin, Edward D. Karoly, Ivan Spasojević, Jian Yang, Kenneth W. Kinzler, Yiping He, Darell D. Bigner, Bert Vogelstein, Hai Yan	359
17	Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1 2007 ·Blood ·Bas J. Wouters, Meritxell Alberich-Jordà, Karen Keeshan, (unknown), Claudia Erpelinck-Verschueren, (unknown), Anton W. Langerak, Yiping He, Yumi Yashiro–Ohtani, Pu Zhang, Christopher J. Hetherington, Roel G.W. Verhaak, Peter J.M. Valk, Bob Löwenberg, Daniel G. Tenen, Warren S. Pear, Ruud Delwel	142
18	Detection and quantification of mutations in the plasma of patients with colorectal tumors breakdown → 2005 ·Proceedings of the National Academy of Sciences ·Frank Diehl, Meng Li, Devin Dressman, Yiping He, Dong Shen, Steve Szabo, Luis A. Díaz, Steven N. Goodman, Kerstin A. David, Hartmut Juhl, Kenneth W. Kinzler, Bert Vogelstein	939

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact